Published in Int J Radiat Oncol Biol Phys on March 15, 1997
Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest (2007) 2.52
Transforming growth factor-beta in breast cancer: too much, too late. Breast Cancer Res (2009) 1.51
Blood flow influences vascular growth during tumour angiogenesis. Br J Cancer (1999) 1.12
Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias. Clin Cancer Res (2009) 0.92
Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts. Invest New Drugs (2002) 0.88
HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance. Mol Cancer Res (2011) 0.86
Biologically conformal treatment: biomarkers and functional imaging in radiation oncology. Future Oncol (2008) 0.79
Oxymetry deep in tissues with low-frequency electron paramagnetic resonance. Proc Natl Acad Sci U S A (1994) 2.53
Complications and diagnosis of Meckel's diverticulum in 776 patients. Am J Surg (1992) 2.48
Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J Biol Chem (1985) 2.45
The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1. Eur J Biochem (1992) 2.26
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol (1992) 2.10
Overexpression of metallothionein confers resistance to anticancer drugs. Science (1988) 2.03
Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res (1981) 1.91
Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood (1996) 1.85
Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery (1995) 1.82
Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle. J Biol Chem (1992) 1.79
Quality of life after gastrectomy in patients with carcinoma of the stomach. Br J Surg (1992) 1.76
An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group. Oncology (1999) 1.75
Myosin II activation promotes neurite retraction during the action of Rho and Rho-kinase. Genes Cells (1998) 1.71
A novel mechanism for the Ca(2+)-sensitizing effect of protein kinase C on vascular smooth muscle: inhibition of myosin light chain phosphatase. J Gen Physiol (1994) 1.70
Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg (2010) 1.68
Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer (1997) 1.67
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer (2000) 1.67
Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A (1993) 1.63
Identification, phosphorylation, and dephosphorylation of a second site for myosin light chain kinase on the 20,000-dalton light chain of smooth muscle myosin. J Biol Chem (1986) 1.62
Phosphorylation of the 20,000-dalton light chain of smooth muscle myosin by the calcium-activated, phospholipid-dependent protein kinase. Phosphorylation sites and effects of phosphorylation. J Biol Chem (1987) 1.60
Reconstitution of protein kinase C-induced contractile Ca2+ sensitization in triton X-100-demembranated rabbit arterial smooth muscle. J Physiol (1999) 1.59
Feasibility of left lobe living donor liver transplantation between adults: an 8-year, single-center experience of 107 cases. Am J Transplant (2006) 1.57
Zipper-interacting protein kinase induces Ca(2+)-free smooth muscle contraction via myosin light chain phosphorylation. J Biol Chem (2001) 1.55
Calcium-dependent enhancement of calcium current in smooth muscle by calmodulin-dependent protein kinase II. Nature (1992) 1.48
Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by Rho-kinase. J Biol Chem (1997) 1.48
Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol (1992) 1.45
Revisiting the safety of living liver donors by reassessing 441 donor hepatectomies: is a larger hepatectomy complication-prone? Am J Transplant (2014) 1.44
Retracted A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int J Radiat Oncol Biol Phys (1989) 1.43
Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. Radiology (1995) 1.42
Effects of the regulatory light chain phosphorylation of myosin II on mitosis and cytokinesis of mammalian cells. J Biol Chem (2000) 1.39
Effectiveness of extended lymphadenectomy in noncurative gastrectomy. Am J Surg (1995) 1.39
Impact of human T cell leukemia virus type 1 in living donor liver transplantation. Am J Transplant (2012) 1.39
Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg (2013) 1.37
Proteolysis of smooth muscle myosin by Staphylococcus aureus protease: preparation of heavy meromyosin and subfragment 1 with intact 20 000-dalton light chains. Biochemistry (1985) 1.36
Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome. J Clin Invest (1996) 1.35
Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol (1997) 1.35
Effects of Ca2+ on the conformation and enzymatic activity of smooth muscle myosin. J Biol Chem (1985) 1.35
Endoscopic diagnosis of early carcinoma of the esophagus using Lugol's solution. Gastrointest Endosc (1993) 1.33
Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res (2001) 1.33
A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma. Oncogene (2001) 1.33
Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br J Cancer (2012) 1.33
The core of the motor domain determines the direction of myosin movement. Nature (2001) 1.32
Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses. J Am Coll Surg (1997) 1.31
Effects of modulators of myosin light-chain kinase activity in single smooth muscle cells. Nature (1989) 1.30
Correlation of enzymatic properties and conformation of smooth muscle myosin. Biochemistry (1983) 1.29
Mutagenesis of the phosphorylation site (serine 19) of smooth muscle myosin regulatory light chain and its effects on the properties of myosin. Biochemistry (1994) 1.29
Left lobe living donor liver transplantation in adults. Am J Transplant (2012) 1.26
Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res (2000) 1.26
Development and assessment of morphologic criteria for diagnosing gastric cancer using confocal endomicroscopy: an ex vivo and in vivo study. Endoscopy (2006) 1.24
The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem Pharmacol (1980) 1.24
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res (1987) 1.23
Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer (1993) 1.22
Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Radiat Res (1996) 1.21
Ca(2+)-dependent regulation of the motor activity of myosin V. J Biol Chem (2000) 1.20
Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Cancer Lett (1999) 1.20
Effects of mutations in the gamma-phosphate binding site of myosin on its motor function. J Biol Chem (1998) 1.19
Surgical results of perforated gastric carcinoma: an analysis of 155 Japanese patients. Am J Gastroenterol (1997) 1.18
Precise assessment of microsatellite instability using high resolution fluorescent microsatellite analysis. Nucleic Acids Res (1997) 1.18
Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg (1995) 1.17
Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg (1994) 1.17
Diminished aqueous microviscosity of tumors in murine models measured with in vivo radiofrequency electron paramagnetic resonance. Cancer Res (1999) 1.16
Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Cancer Res (1986) 1.15
Myosin-I nomenclature. J Cell Biol (2001) 1.14
Dipyridamole inhibits early wound healing in rat skin incisions. J Surg Res (1994) 1.14
Incidence of venous thromboembolism following major abdominal surgery: a multi-center, prospective epidemiological study in Japan. J Thromb Haemost (2006) 1.14
Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg (2005) 1.13
Signaling pathways underlying eosinophil cell motility revealed by using caged peptides. Proc Natl Acad Sci U S A (1998) 1.13
Correlation of ABO blood group with clinicopathologic characteristics of patients with esophageal squamous cell carcinoma. Dis Esophagus (2004) 1.13
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Invest New Drugs (1997) 1.12
Phosphorylation of smooth muscle myosin light chain kinase by Ca2+-activated, phospholipid-dependent protein kinase. J Biol Chem (1985) 1.12
Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res (1981) 1.12
Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus. J Am Coll Surg (1994) 1.11
Functional expression of mammalian myosin I beta: analysis of its motor activity. Biochemistry (1996) 1.10
Formation of the stable myosin-ADP-aluminum fluoride and myosin-ADP-beryllium fluoride complexes and their analysis using 19F NMR. J Biol Chem (1993) 1.10
Preclinical studies and clinical correlation of the effect of alkylating dose. Cancer Res (1988) 1.10
The ATP assay is more sensitive than the succinate dehydrogenase inhibition test for predicting cell viability. Eur J Cancer Clin Oncol (1987) 1.09
Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase. Biochem Biophys Res Commun (2000) 1.09
Correlation between high temperature dependence of smooth muscle myosin light chain phosphatase activity and muscle relaxation rate. J Biol Chem (1994) 1.09
A clinicopathologic study of mucinous gastric carcinoma. Cancer (1992) 1.08
Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. Oncology (2001) 1.08
Lung cancer with p53 expression and a solitary metastasis to the stomach: a case report. Ann Thorac Cardiovasc Surg (2001) 1.08
Synchronous multiple colorectal adenocarcinomas. J Surg Oncol (1997) 1.07
High affinity Ca2+ binding sites of calmodulin are critical for the regulation of myosin Ibeta motor function. J Biol Chem (1998) 1.07
Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol (2001) 1.07
Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy. Int J Cancer (1995) 1.06
Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers. Cancer Lett (2000) 1.04
Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res (2000) 1.03
Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer. Dis Esophagus (2007) 1.00
Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer (1996) 1.00
Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II). J Biol Chem (1990) 1.00
Introduction of high molecular weight (IgG) proteins into receptor coupled, permeabilized smooth muscle. Cell Calcium (1994) 1.00
Clinical significance of vascular endothelial growth factor expression in gastric cancer. J Exp Clin Cancer Res (2002) 1.00
Motor function and regulation of myosin X. J Biol Chem (2001) 0.99
Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells. Oncogene (2011) 0.99
Autophosphorylation of smooth muscle myosin light chain kinase at its regulatory domain. Biochemistry (1995) 0.99
Cloning of sequences expressed specifically in tumors of rat. Proc Natl Acad Sci U S A (1983) 0.99
Prediction of the chemosensitivity of lung cancer by 99mTc-hexakis-2-methoxyisobutyl isonitrile SPECT. J Nucl Med (1999) 0.98
Comparison of the effects of 2,3-butanedione monoxime on force production, myosin light chain phosphorylation and chemical energy usage in intact and permeabilized smooth and skeletal muscles. J Muscle Res Cell Motil (1994) 0.98
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma. J Natl Cancer Inst (1992) 0.98